Objective
A variety of cardiovascular disorders provoke the heart to enlarge through hypertrophic growth of cardiomyocytes, resulting in heart failure and sudden death. Based on in vivo and in vitro models of cardiac hypertrophy, it is apparent that histone-modifying enzymes act as key regulators of cardiac growth. Although their upstream regulation has been studied, the mechanism whereby class IIa Histone deacetylases (HDACs) repress transcription has not been elucidated.
In preliminary studies, we performed an association screen with the Class IIa HDAC4 and a heart cDNA library, and identified the protein ENIGMA as an HDAC4 binding partner. Further studies showed that other PDZ and LIM proteins do not bind class IIa HDACs, and that ENIGMA can bind class I HDACs with its PDZ domain and class IIa HDACs with its 3LIM domain. These novel preliminary results give rise to our main hypothesis that Enigma is a protein scaffold anchoring class I HDACs to class IIa HDACs to create a complex with high deacetylase activity that represses cardiac hypertrophy.
A combination of detailed studies will be conducted to gain an understanding of the composition of this protein complex and its biological role. Specifically, I propose to (1) map the interactions between class IIa HDACs and ENIGMA in detail; (2) determine the endogenous class I HDACs-ENIGMA-Class IIa HDACs' ternary complex; and (3) determine the role of the ENIGMA complex in suppressing hypertrophy in vivo.
Multidisciplinary approaches will be used to examine this hypothesis. Biochemical and molecular biology methods, as well as yeast assays, will be used to assess the interaction between ENIGMA and the HDACs. Further cell biology studies will examine the biological role of the ENIGMA ternary complex in cardiomyocytes in primary cultures, using a novel tissue engineered cardiac construct, and using a gene targeted mouse model. These studies will provide important insights into the mechanisms of cardiac hypertrophy.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences cell biology
- medical and health sciences clinical medicine cardiology
- natural sciences biological sciences biochemistry biomolecules proteins enzymes
- natural sciences biological sciences molecular biology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2011-CIG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MC-CIG - Support for training and career development of researcher (CIG)
Coordinator
31096 Haifa
Israel
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.